Indian Immunologicals is planning to set up a new manufacturing facility in Karkapatla in Ranga Reddy district of Telangana with an investment of Rs. 2500 million. The new facility will make vaccines against infectious diseases of humans & animal health formulations and will have a capacity of 8 million doses of human rabies vaccine. . The animal health formulation facility is equipped to produce 300 million tablets, 100 million bolus (animal vaccine), and 20 million vials of injectables.
Company Profile : Indian Immunologicals Ltd
Leave a Reply